Business Description
Biogen Inc
NAICS : 325412
SIC : 2834
ISIN : US09062X1037
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 3.1 | |||||
Interest Coverage | 7.39 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.3 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.8 | |||||
3-Year EBITDA Growth Rate | -26.7 | |||||
3-Year EPS without NRI Growth Rate | -11.1 | |||||
3-Year FCF Growth Rate | -28.1 | |||||
3-Year Book Growth Rate | 13.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 7.48 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.82 | |||||
9-Day RSI | 44.87 | |||||
14-Day RSI | 42.93 | |||||
6-1 Month Momentum % | -7.7 | |||||
12-1 Month Momentum % | -23.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.29 | |||||
Quick Ratio | 1.48 | |||||
Cash Ratio | 0.61 | |||||
Days Inventory | 366.1 | |||||
Days Sales Outstanding | 79.34 | |||||
Days Payable | 62.64 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.7 | |||||
Shareholder Yield % | -1.91 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.54 | |||||
Operating Margin % | 20.31 | |||||
Net Margin % | 11.98 | |||||
FCF Margin % | 15.23 | |||||
ROE % | 7.74 | |||||
ROA % | 4.34 | |||||
ROIC % | 8.04 | |||||
3-Year ROIIC % | -39.41 | |||||
ROC (Joel Greenblatt) % | 27.57 | |||||
ROCE % | 6.83 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.11 | |||||
Forward PE Ratio | 11.67 | |||||
PE Ratio without NRI | 12.79 | |||||
Shiller PE Ratio | 9.41 | |||||
Price-to-Owner-Earnings | 65.8 | |||||
PS Ratio | 3 | |||||
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 20.2 | |||||
Price-to-Free-Cash-Flow | 19.77 | |||||
Price-to-Operating-Cash-Flow | 16.26 | |||||
EV-to-EBIT | 21.39 | |||||
EV-to-Forward-EBIT | 12.16 | |||||
EV-to-EBITDA | 15.71 | |||||
EV-to-Forward-EBITDA | 9.08 | |||||
EV-to-Revenue | 3.49 | |||||
EV-to-Forward-Revenue | 3.6 | |||||
EV-to-FCF | 23.02 | |||||
Price-to-Projected-FCF | 0.65 | |||||
Price-to-Median-PS-Value | 0.7 | |||||
Price-to-Graham-Number | 3.39 | |||||
Earnings Yield (Greenblatt) % | 4.68 | |||||
FCF Yield % | 5.05 | |||||
Forward Rate of Return (Yacktman) % | -9.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8,956.28 | ||
EPS (TTM) (€) | 7.328 | ||
Beta | 0.02 | ||
Volatility % | 22 | ||
14-Day RSI | 42.93 | ||
14-Day ATR (€) | 2.793562 | ||
20-Day SMA (€) | 180.8 | ||
12-1 Month Momentum % | -23.59 | ||
52-Week Range (€) | 174 - 253.2 | ||
Shares Outstanding (Mil) | 145.66 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biogen Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biogen Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Biogen Inc Frequently Asked Questions
What is Biogen Inc(FRA:IDP)'s stock price today?
When is next earnings date of Biogen Inc(FRA:IDP)?
Does Biogen Inc(FRA:IDP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |